PHARMAIDS PHARMACEUTICALS LTD. Share Price
PHARMAIDS PHARMACEUTICALS LTD. Share Price Today
As of 25 Jul 2026, PHARMAIDS PHARMACEUTICALS LTD. share price is ₹30.40. The stock opened at ₹31.85, compared to its previous close of ₹30.54. During today's trading session, PHARMAIDS PHARMACEUTICALS LTD. share price moved in the range of ₹30.10 to ₹31.85, with an average price of ₹30.98 for the day. Looking at its last 52-week, the stock has touched a low of ₹25.60 and a high of ₹69.90.
PHARMAIDS PHARMACEUTICALS LTD. Returns Calculator
PHARMAIDS PHARMACEUTICALS LTD. Shareholder Returns
PHARMAIDS PHARMACEUTICALS LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,65,711.00 | 36.73 | 5.05 | 14.85% | 0.55 | 18.72% | 18.85 | 0.91% | 0.56 | 10.90 |
| Divis Laboratories | 1,93,860.00 | 61.36 | 9.40 | 16.19% | 0.00 | 21.00% | 9.43 | 0.50% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,92,687.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,12,593.00 | 33.55 | 3.27 | 11.27% | 0.00 | 14.95% | 423.36 | 0.93% | 0.44 | 43.52 |
| Zydus Lifesciences | 1,11,082.00 | 17.39 | 3.23 | 19.69% | 0.35 | 20.30% | 3.70 | 0.11% | 0.39 | 35.38 |
| Lupin | 1,09,553.00 | 19.83 | 4.71 | 27.01% | 0.03 | 27.44% | 3.51 | 0.78% | 0.61 | 129.18 |
| Mankind Pharma | 1,05,607.00 | 1.05 | 0.12 | 12.65% | 0.42 | 12.97% | 5.05 | 0.05% | 0.54 | 49.37 |
| Dr. Reddy's Laboratories | 96,204.70 | 30.22 | 2.53 | 11.07% | 0.18 | 12.54% | 377.96 | 0.69% | 0.41 | 38.68 |
| Aurobindo Pharma | 88,508.40 | 25.27 | 2.34 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 84,727.30 | 60.26 | 10.10 | 18.21% | 0.40 | 16.70% | 97.21 | 0.12% | 0.64 | 13.72 |
PHARMAIDS PHARMACEUTICALS LTD. Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹19.45 | ₹15.11 | ₹0.00 | ₹3.94 |
| Other Income | ₹0.10 | ₹0.88 | ₹0.00 | ₹0.02 |
| Total Revenue | ₹19.55 | ₹15.99 | ₹0.00 | ₹3.95 |
| Total Expenses | ₹36.73 | ₹30.79 | ₹9.91 | ₹3.81 |
| Profit Before Tax | -₹17.28 | -₹15.62 | -₹9.91 | ₹0.14 |
| Tax | -₹3.77 | -₹3.78 | -₹2.35 | ₹0.00 |
| Profit After Tax | -₹13.51 | -₹11.84 | -₹7.56 | ₹0.15 |
| EPS - Basic | -₹3.05 | -₹3.56 | -₹5.86 | ₹0.14 |
| EPS - Diluted | -₹3.05 | -₹3.56 | -₹5.86 | ₹0.14 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹17.28 | -₹15.62 | -₹9.91 | ₹0.14 |
| Income before WC changes | -₹12.47 | -₹11.74 | -₹9.86 | ₹0.15 |
| Change in Assets | -₹16.42 | ₹0.55 | ₹6.15 | -₹0.30 |
| Change in Liabilities | ₹14.96 | ₹0.57 | -₹0.31 | -₹0.11 |
| Change in WC | -₹1.46 | ₹1.12 | ₹5.84 | -₹0.41 |
| Cash flow from Operations | -₹13.99 | -₹10.62 | -₹4.02 | -₹0.26 |
| Cash flow from Investing | -₹12.02 | -₹74.99 | -₹4.94 | ₹0.47 |
| Cash flow from Financing | ₹23.36 | ₹77.66 | ₹21.31 | ₹0.00 |
| Total Cash Flow | -₹2.66 | -₹7.95 | ₹12.35 | ₹0.21 |
| Cash (Start of the year) | ₹4.80 | ₹12.75 | ₹0.41 | ₹0.20 |
| Cash (End of the year) | ₹2.14 | ₹4.80 | ₹12.75 | ₹0.41 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹97.55 | ₹77.81 | ₹7.07 | ₹8.44 |
| Current Assets | ₹22.31 | ₹13.53 | ₹17.51 | ₹2.67 |
| Total Assets | ₹119.85 | ₹91.34 | ₹24.59 | ₹11.11 |
| Current Liabilities | ₹28.71 | ₹11.58 | ₹2.13 | ₹2.44 |
| Net Current Asset | -₹6.41 | ₹1.96 | ₹15.39 | ₹0.23 |
| Non-Current Liabilities | ₹36.10 | ₹9.27 | ₹0.00 | ₹0.00 |
| Equity Capital | ₹55.04 | ₹70.50 | ₹22.46 | ₹8.67 |
| Total Equity & Liabilities | ₹119.85 | ₹91.34 | ₹24.59 | ₹11.11 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹2.34 | ₹0.03 | ₹0.00 | ₹3.94 |
| Other Income | ₹1.02 | ₹0.80 | ₹0.00 | ₹0.02 |
| Total Revenue | ₹3.36 | ₹0.82 | ₹0.00 | ₹3.95 |
| Total Expenses | ₹11.95 | ₹6.91 | ₹9.91 | ₹3.81 |
| Profit Before Tax | -₹8.59 | -₹6.09 | -₹9.91 | ₹0.14 |
| Tax | -₹1.31 | -₹1.14 | -₹2.35 | ₹0.00 |
| Profit After Tax | -₹7.28 | -₹4.95 | -₹7.56 | ₹0.15 |
| EPS - Basic | -₹2.06 | -₹2.18 | -₹5.86 | ₹0.14 |
| EPS - Diluted | -₹2.06 | -₹2.18 | -₹5.86 | ₹0.14 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹8.59 | -₹6.09 | -₹9.91 | ₹0.14 |
| Income before WC changes | -₹6.62 | -₹3.44 | -₹9.86 | ₹0.15 |
| Change in Assets | -₹15.16 | ₹1.33 | ₹6.16 | -₹0.30 |
| Change in Liabilities | ₹14.05 | -₹1.33 | -₹0.32 | -₹0.11 |
| Change in WC | -₹1.11 | ₹0.00 | ₹5.84 | -₹0.41 |
| Cash flow from Operations | -₹7.72 | -₹3.44 | -₹4.02 | -₹0.26 |
| Cash flow from Investing | -₹18.90 | -₹72.51 | -₹4.94 | ₹0.47 |
| Cash flow from Financing | ₹24.64 | ₹65.66 | ₹21.31 | ₹0.00 |
| Total Cash Flow | -₹1.99 | -₹10.29 | ₹12.35 | ₹0.21 |
| Cash (Start of the year) | ₹2.46 | ₹12.75 | ₹0.41 | ₹0.20 |
| Cash (End of the year) | ₹0.47 | ₹2.46 | ₹12.75 | ₹0.41 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹106.01 | ₹80.24 | ₹6.27 | ₹8.44 |
| Current Assets | ₹12.68 | ₹4.76 | ₹18.28 | ₹2.67 |
| Total Assets | ₹118.69 | ₹85.00 | ₹24.55 | ₹11.11 |
| Current Liabilities | ₹15.23 | ₹1.10 | ₹2.12 | ₹2.44 |
| Net Current Asset | -₹2.55 | ₹3.66 | ₹16.16 | ₹0.23 |
| Non-Current Liabilities | ₹39.67 | ₹12.84 | ₹0.00 | ₹0.00 |
| Equity Capital | ₹63.79 | ₹71.06 | ₹22.43 | ₹8.67 |
| Total Equity & Liabilities | ₹118.69 | ₹85.00 | ₹24.55 | ₹11.11 |
About PHARMAIDS PHARMACEUTICALS LTD.
Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs, and intermediaries, and other. The Company operates through Bulk Drugs and Intermediates segment. Its specialty chemicals products include Retinol, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Duojoint, and other.
PHARMAIDS PHARMACEUTICALS LTD. Financial Highlights
- Revenue: PHARMAIDS PHARMACEUTICALS LTD. reported revenue of ₹28.17 crore in FY26 vs ₹19.55 crore in FY25. It showed an increase of 44.09% on a yearly basis.
- Operating Profit: PHARMAIDS PHARMACEUTICALS LTD. reported an operating loss of ₹16.30 crore in FY26 vs ₹17.28 crore in FY25. It showed an increase of 5.67% on a year-on-year basis.
- Net Profit: PHARMAIDS PHARMACEUTICALS LTD. reported a net loss of ₹11.57 crore in FY26 vs ₹13.51 crore in FY25. It showed an increase of 14.36% on a yearly basis.
PHARMAIDS PHARMACEUTICALS LTD. Quarterly Result Highlights
- PHARMAIDS PHARMACEUTICALS LTD. reported revenue of ₹7.28 crore in Mar 2026, compared with ₹5.51 crore in Dec 2025, representing an increase of 32.12% on a quarter-on-quarter (QoQ) basis.
- PHARMAIDS PHARMACEUTICALS LTD. reported an operating loss of ₹1.46 crore in Mar 2026, compared with ₹4.02 crore in Dec 2025, representing an increase of 63.68% on a quarter-on-quarter (QoQ) basis.
- PHARMAIDS PHARMACEUTICALS LTD. reported a loss of ₹1.08 crore in Mar 2026, compared with ₹2.65 crore in Dec 2025, reflecting an increase of 59.25% on a QoQ basis.
- The earnings per share (EPS) of PHARMAIDS PHARMACEUTICALS LTD. stood at ₹3.05 during Mar 2026.
Similar Stocks
FAQs on PHARMAIDS PHARMACEUTICALS LTD. Share Price
What is PHARMAIDS PHARMACEUTICALS LTD. share price today?
PHARMAIDS PHARMACEUTICALS LTD. share price is ₹30.40 as on 24 Jul, 2026, 15:29 IST.
How has the PHARMAIDS PHARMACEUTICALS LTD. share price performed in the past?
In the last 1 year, PHARMAIDS PHARMACEUTICALS LTD. delivered a return of -53.46%. The PHARMAIDS PHARMACEUTICALS LTD. share price hit a high of ₹69.90 and low of ₹25.60.
How much is the Mutual Fund shareholding in PHARMAIDS PHARMACEUTICALS LTD. shares?
The Mutual Fund Shareholding in PHARMAIDS PHARMACEUTICALS LTD. was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of PHARMAIDS PHARMACEUTICALS LTD. shares ?
The 52-week high and low of PHARMAIDS PHARMACEUTICALS LTD. share is ₹69.90 and ₹25.60 as of 24 Jul, 2026.
What is the market cap of PHARMAIDS PHARMACEUTICALS LTD.?
The market capitalisation of PHARMAIDS PHARMACEUTICALS LTD. is ₹107.71 Crores as on 24 Jul, 2026.
What are the stock symbols of PHARMAIDS PHARMACEUTICALS LTD.?
The stock symbol of PHARMAIDS PHARMACEUTICALS LTD. is 524572 on the BSE, and the ISIN is INE117D01018.
What was yesterday's closing price for PHARMAIDS PHARMACEUTICALS LTD. shares ?
PHARMAIDS PHARMACEUTICALS LTD. shares closed yesterday at ₹30.54 on BSE
How to buy PHARMAIDS PHARMACEUTICALS LTD. shares?
To buy PHARMAIDS PHARMACEUTICALS LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy PHARMAIDS PHARMACEUTICALS LTD. shares on Holidays?
No, shares of PHARMAIDS PHARMACEUTICALS LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell PHARMAIDS PHARMACEUTICALS LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of PHARMAIDS PHARMACEUTICALS LTD.?
The PE and PB ratio of PHARMAIDS PHARMACEUTICALS LTD. is -9.33 and 2.26 respectively, as on 24 Jul, 2026, 15:29 IST.
